Revolution Medicines Inc
NASDAQ:RVMD
Cash Flow Statement
Cash Flow Statement
Revolution Medicines Inc
Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||||||||
Net Income |
(62)
|
(44)
|
(48)
|
(57)
|
(74)
|
(89)
|
(108)
|
(126)
|
(143)
|
(169)
|
(187)
|
(208)
|
(224)
|
(245)
|
(249)
|
(259)
|
(296)
|
(331)
|
(436)
|
(484)
|
|
Depreciation & Amortization |
3
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
5
|
6
|
6
|
6
|
6
|
|
Change in Deffered Taxes |
0
|
0
|
(4)
|
(5)
|
(5)
|
(5)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(4)
|
(4)
|
0
|
|
Stock-Based Compensation |
2
|
3
|
3
|
4
|
6
|
8
|
9
|
11
|
14
|
17
|
21
|
24
|
27
|
29
|
31
|
34
|
39
|
45
|
62
|
0
|
|
Other Non-Cash Items |
5
|
3
|
4
|
5
|
7
|
10
|
13
|
15
|
19
|
23
|
27
|
31
|
33
|
34
|
33
|
32
|
31
|
32
|
43
|
37
|
|
Change in Working Capital |
31
|
(11)
|
(4)
|
(11)
|
(5)
|
(7)
|
(8)
|
(3)
|
(4)
|
8
|
9
|
7
|
(0)
|
5
|
(13)
|
(9)
|
17
|
6
|
41
|
(4)
|
|
Cash from Operating Activities |
(23)
N/A
|
(50)
-117%
|
(50)
+0%
|
(65)
-31%
|
(74)
-13%
|
(87)
-18%
|
(100)
-15%
|
(109)
-9%
|
(123)
-13%
|
(133)
-8%
|
(147)
-11%
|
(165)
-12%
|
(187)
-13%
|
(202)
-8%
|
(224)
-11%
|
(232)
-3%
|
(243)
-5%
|
(292)
-20%
|
(351)
-20%
|
(449)
-28%
|
|
Investing Cash Flow | |||||||||||||||||||||
Capital Expenditures |
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(6)
|
(7)
|
(7)
|
(7)
|
(5)
|
(6)
|
(9)
|
(11)
|
(11)
|
(9)
|
(8)
|
(8)
|
(9)
|
|
Other Items |
(49)
|
(108)
|
(99)
|
(165)
|
(245)
|
(287)
|
(231)
|
(166)
|
(152)
|
(81)
|
(136)
|
(96)
|
91
|
1
|
(13)
|
(53)
|
(161)
|
39
|
(335)
|
(585)
|
|
Cash from Investing Activities |
(52)
N/A
|
(110)
-114%
|
(102)
+7%
|
(167)
-64%
|
(248)
-48%
|
(289)
-17%
|
(234)
+19%
|
(172)
+26%
|
(158)
+8%
|
(88)
+45%
|
(142)
-62%
|
(100)
+29%
|
85
N/A
|
(8)
N/A
|
(24)
-184%
|
(64)
-166%
|
(170)
-165%
|
31
N/A
|
(343)
N/A
|
(595)
-74%
|
|
Financing Cash Flow | |||||||||||||||||||||
Net Issuance of Common Stock |
151
|
105
|
100
|
354
|
262
|
421
|
423
|
451
|
454
|
285
|
295
|
13
|
13
|
261
|
301
|
625
|
689
|
441
|
392
|
69
|
|
Other |
0
|
(0)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
837
|
0
|
|
Cash from Financing Activities |
151
N/A
|
104
-31%
|
99
-6%
|
352
+257%
|
261
-26%
|
420
+61%
|
423
+1%
|
451
+7%
|
454
+0%
|
285
-37%
|
294
+3%
|
12
-96%
|
13
+4%
|
261
+1 941%
|
301
+16%
|
625
+107%
|
689
+10%
|
441
-36%
|
1 229
+179%
|
906
-26%
|
|
Change in Cash | |||||||||||||||||||||
Net Change in Cash |
77
N/A
|
(55)
N/A
|
(53)
+4%
|
120
N/A
|
(61)
N/A
|
44
N/A
|
88
+102%
|
170
+92%
|
172
+1%
|
64
-63%
|
5
-92%
|
(253)
N/A
|
(89)
+65%
|
50
N/A
|
53
+5%
|
330
+523%
|
275
-16%
|
180
-35%
|
536
+198%
|
(138)
N/A
|
|
Free Cash Flow | |||||||||||||||||||||
Free Cash Flow |
(25)
N/A
|
(52)
-105%
|
(52)
0%
|
(68)
-30%
|
(76)
-12%
|
(89)
-17%
|
(103)
-16%
|
(115)
-12%
|
(130)
-13%
|
(139)
-7%
|
(154)
-10%
|
(170)
-11%
|
(193)
-13%
|
(211)
-9%
|
(235)
-11%
|
(242)
-3%
|
(252)
-4%
|
(300)
-19%
|
(358)
-19%
|
(458)
-28%
|